EQT Holdings Limited
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| EQT.AX | PVQ.F | EQH | LWDB.L | ENS.TO | GQG.AX | |
|---|---|---|---|---|---|---|
| Market cap | 579.08M | 1.21B | 14.39B | 1.55B | 338.70M | 2.98B |
| P/E (TTM) | 17.0 | 35.9 | — | 5.1 | 2.5 | 4.1 |
| Forward P/E | 15.9 | — | 5.9 | — | — | 5.7 |
| Price/book | 1.4 | 1.2 | -7.8 | 1.2 | 0.8 | 4.5 |
| Dividend yield | 1.85% | 7.46% | 2.07% | 0.03% | 10.34% | 20.85% |
| 1-year change | −8.52% | −1.89% | +12.60% | +9.83% | +8.34% | −38.58% |
| Today | −1.91% | +4.00% | −4.16% | +0.52% | +1.82% | −1.49% |
The closest companies by business and industry (Asset Management). Prices may be delayed up to 20 min.
Latest news
All EQT.AX news ›Qiagen agrees to €46.50/share all-cash takeover offer from EQT
Qiagen agreed to a €10.8B all-cash EQT takeover at €46.50 a share. Qiagen (QGEN) on Thursday said it has agreed on an all-cash public takeover from private equity firm EQT valuing the European molecular testing company at about €10.8…
EQT-backed Sagility acquires clinical documentation and coding firm Chirok Health
Founded in 2020, the company provides audit, quality assurance and revenue cycle services to healthcare providers across fee-for-service and value-based care models. EQT-backed Sagility acquires clinical documentation and coding firm…
EQT strikes €10.8bn deal to take Qiagen private at 40.3% premium
PEI Private Equity EQT strikes €10.8bn deal to take Qiagen private at 40.3% premium Qiagen is a Dutch life science tools and diagnostics company listed in Frankfurt and New York. LLCP completes sale of Global Loan Agency Services to Oakley…
EQT To Acquire QIAGEN In €10.8 Billion Take-Private With ADIA And CPP Investments
QIAGEN has entered into an agreement supporting an all-cash voluntary public takeover offer from EQT Private Equity that values the life sciences and molecular diagnostics company at approximately €10.8 billion in enterprise value, or…
EQT agrees EUR 10.8bn takeover of Qiagen
Global Regulatory Strategy Lead, Senior Director Faglig rådgiver til ATMP Danmark Senior Drug Substance Scientist Head of Clinical Operations Senior Drug Product Filling Specialist Head of Medical Affairs International Markets Chef for…
Qiagen set for private ownership as EQT proposes $10.8bn takeover deal
Molecular testing firm Qiagen has agreed to a $52.22-per-share all-cash acquisition by EQT Private Equity. Related:Teva inks Emalex buyout for up to $900m The boards concluded unanimously that moving to private ownership under EQT offers…
EQT to Acquire Qiagen for $12.1B, Plans to Take Tools, Diagnostics Provider Private
An entity of Swedish private equity firm EQT has agreed to acquire Qiagen for €10.8 billion (about $12.1 billion) cash, both said today, in a deal that would take private the global life-sciences tools, diagnostics, and workflow solutions…
EQT to Acquire Qiagen for About €9.6 Billion
Briefs Finance helps everyday people get better with money and invest with confidence, from getting out of debt all the way to investing like an expert. It starts with Market Briefs, a free five-minute daily newsletter, and grows into…
DNB invests EUR 10m in EQT’s Scaleup Europe Fund
The bank positions itself as the first Nordic participant in the EU-backed growth fund targeting strategic technologies. DNB invests EUR 10m in EQT’s Scaleup Europe Fund The bank positions itself as the first Nordic participant in the…
Qiagen agrees to go private with €10.8B takeover by EQT
Swedish private equity firm EQT wants to acquire diagnostics specialist Qiagen for €10.8 billion, or €46.50 per share. The company’s leadership unanimously supports the sale. Completion is planned for mid-2027 if more than 50% of…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com72
-
tradingview.com26
-
gurufocus.com12
-
kalkinemedia.com12
-
seekingalpha.com9
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.